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Abstract: Venous blood was drawn from 35 pregnant Hispanic women living in 
Brownsville, Texas, and matched cord blood was collected at birth. Gas 
chromatography/mass spectrometry was used to measure concentrations of 55 individual 
PAHs or groups of PAHs. Results indicate that these women and their fetuses were 
regularly exposed to multiple PAHs at comparatively low concentrations, with levels in 
cord blood generally exceeding levels in paired maternal blood. While the possibility of  
related adverse effects on the fetus is uncertain, these exposures in combination with 
socioeconomically-disadvantaged and environmentally-challenging living conditions raise 
legitimate public health concerns. 
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1. Introduction 
There is convincing evidence that exposures to a variety of environmental chemicals can have 
adverse effects on children’s health [1-8]. The developing fetus and neonates are particularly at risk 
because they are known to be more susceptible than adults to the toxicological consequences of 
numerous environmental chemicals, including environmental tobacco smoke (ETS), lead (Pb), 
mercury (Hg), organochlorine and organophosphate pesticides, polychlorinated biphenyls (PCBs), and 
polycyclic aromatic hydrocarbons (PAHs) [1,2,7,9-11]. This increased sensitivity is attributable to, 
among other factors, higher rates of cell proliferation, decreased capability to activate and detoxify 
carcinogenic compounds, and lower immune-response capacity [7,9,12]. Prenatal exposure to PAHs is 
a particularly high-priority public health concern because these compounds are ubiquitous in various 
environmental media (e.g., air, water, soil, food), readily cross the placenta from mother to fetus, are 
known human carcinogens and suspected developmental and reproductive toxicants, and exposures 
have been documented for both pregnant women and their fetuses [13-18]. 
Chemicals classified as PAHs are made up of two or more fused benzene rings, and include 
hundreds of compounds [19], ranging in complexity from naphthalene (two rings), to phenanthrene 
and anthracene (three rings), to the more common five- or six-ring chemicals, like benzo(a)pyrene 
(five rings) and dibenz(a,h)anthracene (six rings). PAHs are produced as by-products of incomplete 
combustion of organic substances, and can also be found in crude oil, coal, coal tar pitch, creosote, 
roofing tar, and asphalt used for road construction. People are typically exposed to a complex mixture 
of PAHs from ingesting smoked, grilled, barbecued, or burned foods, eating contaminated uncooked 
foods (e.g., grown in contaminated soil), inhaling wood or tobacco smoke, breathing contaminated 
indoor or outdoor air (e.g., vehicle exhaust, incinerator emissions, fumes from asphalt roads and 
roofing tar), ingesting contaminated house dust and soil, drinking contaminated tap water (e.g., 
leaching from coal tar and asphalt linings in storage tanks and distribution lines), and skin contact with 
creosote-treated wood [20,21]. 
Although PAHs tend to be persistent in the environment, once inside the body they behave more 
like nonpersistent chemicals because they are metabolized rapidly, eliminated in the urine, and only 
small amounts are deposited in biological matrices [4]. Since the half-life of PAHs in blood is a matter 
of hours, concentrations are typically three orders of magnitude lower than urinary metabolite  
levels [4]. Consequently, most biomarker studies looking at PAH exposures have measured either PAH 
metabolites in urine [21] or DNA-PAH adducts in blood [13-18]. This article reports results from a 
novel study to measure actual concentrations of PAHs in blood from pregnant women and matched 
umbilical cords. 
2. Methods  
The investigation was designed to quantify PAH concentrations in whole blood from pregnant 
women and, subsequently, in a sample of cord blood taken at the time of birth. Participants in the study 
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were volunteers recruited from the patient population at a private clinic in Brownsville, Texas (USA). 
Brownsville is located in south Texas along the U.S.-Mexico border, in a region known as the Lower 
Rio Grande Valley (LRGV). According to the U.S. Census Bureau [22], the city has a population of 
172,434, of whom 92% are Hispanic. The 2006 American Community Service Survey ranked 
Brownsville as the most impoverished city in the nation based on average-annual household  
income [22]. More than a third of residents are 18 years old or younger, and 45% live in poverty; the 
highest proportion of any city in the U.S. with a population over 100,000 [22].  
2.1. Subjects 
Pregnant women in their first or second trimester presenting at a private gynecological clinic were 
told about the study and invited to participate. Informed verbal and written consent (either in Spanish 
or English, as appropriate) was obtained from those who agreed. No incentives were provided to 
participants, and the study received approval from the Committee for the Protection of Human 
Subjects at the University of Texas Health Science Center at Houston. Participants completed a short 
questionnaire on demographic and socioeconomic characteristics at the time of enrollment.  
2.2. Specimen Collection and Handling 
Between October 2005 and February 2006, venous blood samples were collected during routine 
clinic visits (third trimester) and cord blood was obtained at birth. The time between collection of 
maternal blood and collection of cord blood varied, with 6 matched maternal-cord sample pairs 
obtained within 24 hours of each other, 10 within 2–14 days, 16 within 15–35 days, and 3 within  
43–57 days. Collection of maternal blood was accomplished by venipuncture, and samples were put 
into a 10 mL, red-topped, vacutainer tub, then labeled, and refrigerated. After the umbilical cord was 
severed at birth, approximately 10 mL of blood were drained into a red-topped plain vacutainer tube, 
which was capped, labeled, and refrigerated. For shipping, each unopened blood tube was sealed with 
Teflon tape and placed upright in an individual slot inside a pressure jar. Gel or ice packs were placed 
under, around, and over the jar, which was then sealed in a shipping container and shipped by 
overnight express to the laboratory. 
2.3. Laboratory Analysis 
All samples were analyzed in the laboratory at the School of Rural Public Health, Texas A&M 
University, in College Station, Texas [23]. Dichloromethane was added to the blood samples to start 
the extraction process once they arrived at the lab. Later, sodium sulfate was added and the mixture 
homogenized three times at 3 minutes per extraction. The combined extracts were filtered and 
concentrated to 3.0 mL. The samples were then cleaned on a silica/alumina column and subjected to 
high-performance liquid chromatography (HPLC). Afterward, samples were concentrated to the final 
volume of 0.5 mL. All blood samples were subsequently analyzed for more than 50 individual PAHs 
(e.g., benzo(a)pyrene) or groups of PAHs (e.g., C3-fluorenes) using a combination of gas 
chromatography and mass spectrometry (GC/MS) according to modified US Environmental Protection 
Agency SW-846 Method 8271C [24]. 
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2.4. Not-Detected and Below-Detection-Limit Values  
A significant fraction of blood samples usually fall below the limit of detection (LOD) in most 
exposure biomarker studies, which requires application of simple yet valid methods for reporting and 
statistically analyzing concentrations <LOD [25,26]. Numerous methods for dealing with left-censored 
(below LOD) data have been proposed [27,28], but there is no scientific consensus about the most 
appropriate one. The U.S. EPAg [29] and several scientists advocate using all instrument-generated 
values, including those <LOD, in order to have a complete and uncensored data set on which to 
perform statistical analyses [30-33]. The method LOD for all blood PAHs analyzed as part of this 
study was approximately 2 ng/mL. Compound-specific LODs and the number of measured blood PAH 
levels that fell into one of three categories (concentrations > LOD; concentrations > 0 but <LOD; and 
no instrument response i.e., no analyte found by GC/MS) are summarized as part of Appendix A in 
Tables A1, A2, and A3. Statistical analyses used the instrument-generated values for the first two 
categories, and one-half (0.05 ng/mL) of the lowest reported concentration for the third category. 
2.5. Data Analysis  
The data were log normal, and geometric means and standard deviations were calculated for the  
35 matched blood pairs and the six matched pairs collected within 24-hours of each other. Paired  
t-tests were used to evaluate whether observed differences between PAHs in cord blood and maternal 
blood were statistically significant. Pearson correlation coefficients were used to examine the strength 
of the statistical relationship between cord and maternal blood concentrations collected within 24 hours 
of each other. 
3. Results 
Demographic and socioeconomic characteristics of the 35 women enrolled in the study are 
summarized in Table 1. All the women were Hispanic, between the ages of 18 and 38 years old, and 
had lived in the Brownsville area for several years. Only one woman identified herself as an active 
smoker (however, her PAH concentrations were unremarkable). The mean height was 5.2 ft and mean 
weight was 161 lbs. The women had an average of 2.6 children at home and the average number of 
previous pregnancies was 2.8. Approximately 63% were born in the U.S., 6% in Mexico, and 31% 
elsewhere or unknown. Twenty percent graduated from high school or completed a GED, and an 
additional 49% graduated from a college or university. Seventy-one percent were married, 26% had 
never been married, and 3% were separated. Forty percent worked in an office, business, or shopping 
mall, 20% were housewives, and 20% were teachers, administrators, or students. 
Table 1. Sociodemographic attributes of women participating in the study (N = 35). 
VARIABLE  MEAN (S.D., Range) 
Age (years)  25.8 (5.5, 18–38) 
Height (feet) 
Weight (pounds) 
 5.2 (0.21, 4.8–5.6) 
 160.9 (36.9, 96–237) 
Previous Pregnancies  2.8 (0.76, 2–4) 
Number of Children  2.6 (0.5, 2–3) 
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Table 1. Cont. 
VARIABLE NUMBER OF WOMEN (%) 
Country of Birth 
 United States 
 Mexico 
 Other or Unknown 
 
 22 (62.9) 
 2 (5.7) 
 11 (31.4) 
Education 
 Middle School 
 Some High School 
 Graduated High School/GED 
 Graduated College/University 
 Unknown 
 
 2 (5.7) 
 8 (22.9) 
 7 (20.0) 
 17 (48.6) 
 1 (2.9)  
Occupation 
 Housewife 
 Office/Business/Shopping Mall 
 Teacher/Student/Administrator 
 Outdoor Job 
 Unemployed 
 Other 
 Unknown 
 
 7 (20.0) 
 14 (40.0) 
 7 (20.0) 
 1 (2.9) 
 1 (2.9) 
 4 (11.4) 
 1 (2.9) 
Marital Status 
 Married 
 Never Married 
 Separated 
 
 25 (71.4) 
 9 (25.7) 
 1 (2.9) 
 
Cord and maternal blood were analyzed for 55 PAHs. As shown in Table 2, 19 compounds (34.5%) 
were not found at all and 10 compounds (18%) were only infrequently measurable. These  
29 compounds were excluded from further statistical analysis but are included as part of the “total 
PAH” (sum of all measureable concentrations above zero) values reported in Tables 3 and 4.  
Table 2. Summary of PAHs either not found or infrequently measurable in maternal and cord blood. 
No Concentration Measureable in 100% of Blood Samples 
                           C1-benzothiphenes                                 C2-chrysenes 
                           C2-benzothiphenes                                 C3-chrysenes 
                           C3-benzothiophenes                               C4-chrysenes 
                           Naphthobenzothiphene                           Benzo(k)fluoranthene 
                           C1-naphthobenzothiophenes                   Benzo(a)pyrene 
                           C2-naphthobenzothiophenes                   Indeno(1,2,3-c,d)pyrene 
                           C3-naphthobenzothiophenes                   Dibenzo(a,h)anthracene 
                           C1-chrysenes                                           Benzo(g,h,i)perylene 
                           C3-phenanthrenes/anthracenes                C3-dibenzothiphenes 
                           C4-phenanthrenes/anthracenes 
           No Concentration Measureable in ≥ 80% to ≤ 99% of Blood Samples  
                         Benzothiophene                                        C1-fluoranthenes/pyrenes 
                           Acenaphthylene                                        C2-fluoranthenes/pyrenes 
                           Carbazole                                                  Benz(a)anthracene 
                         Chrysene                                                   Benzo(e)pyrene  
                           Benzo(b)fluoranthene                               Perylene 
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Summary statistics for the other 26 PAHs and for total PAHs (sum of all concentrations above zero) 
are provided in Table 3. Geometric mean and geometric standard deviation for each compound are 
presented for cord blood, maternal blood, and the ratio of cord-to-maternal blood (C/M ratio). For all 
PAHs, geometric mean concentrations in cord blood are greater than or equal to those in maternal 
blood, and the C/M ratio is ≥ 1 except for acenaphthene. Based on two-tailed t-tests, observed 
differences between cord and maternal blood were statistically significant (p < 0.05) for 17 compounds 
and for total PAHs. The nine PAHs for which concentrations were not statistically different were 
naphthalene, C1-naphthalenes, biphenyl, acenaphthene, C3-fluorenes, 1-methylnaphthalene, 2-methyl- 
naphthalene, 2,6-dimethylnaphthalene, and 1,6,7-trimethylnaphthalene. 
Because most maternal-cord blood pairs (29 out of 35) were collected days to weeks apart, a direct 
comparison implicitly assumes that PAH exposures were relatively constant over the time period that 
data were collected. Although the data exhibit a consistent pattern, with cord PAHs tending to be 
greater than matched maternal values, information necessary to estimate PAH exposures is not 
available, but by focusing on the six matched pairs collected less than 24 hours apart (see Table 4), the 
relationship between PAHs in maternal and cord blood can be explored more directly (i.e., the PAH 
exposure will be the same for both sample types). 
Table 3. Summary statistics for PAH concentrations in matched pairs of maternal and cord 
blood (N = 35).  
COMPOUND 
CORD BLOOD 
GM (GSD) ng/mL 
MATERNAL BLOOD 
GM (GSD) ng/mL 
CORD/MATERNAL RATIO  
GM (GSD) 
Naphthalene  1.5 (1.6)  1.5 (1.3) 1.0 (1.7) 
C1-Naphthalenes  1.1 (1.6)  1.0 (1.5) 1.2 (1.6) 
C2-Naphthalenes  1.5 (1.7)  0.4 (7.8) 3.8 (7.3) 
C3-Naphthalenes  0.8 (4.4)  0.2 (9.5) 4.6 (16.9) 
C4-Naphthalenes  0.3 (10.7)  0.1 (11.9) 2.9 (11.8) 
Biphenyl  0.5 (1.7)  0.5 (1.4) 1.1 (1.9) 
Acenaphthene  0.0 (3.1)  0.0 (3.5) 0.6 (4.2) 
Dibenzofuran  0.4 (1.7)  0.3 (2.9) 1.6 (3.5) 
Fluorene  0.3 (1.9)  0.1 (4.1) 2.9 (4.9) 
C1-Fluorenes  0.7 (2.0)  0.2 (6.5) 4.3 (6.8) 
C2-Fluorenes  0.9 (3.0)  0.1 (8.6) 6.0 (9.8) 
C3-Fluorenes  0.1 (8.8)  0.0 (5.0) 5.0 (23.1) 
Anthracene  0.1 (2.9)  0.0 (3.1) 2.5 (4.3) 
Phenanthrene  0.9 (1.8)  0.5 (2.4) 1.9 (2.6) 
C1-P/A 
a 
 1.0 (2.0)  0.1 (7.3) 8.0 (7.1) 
C2-P/A 
b 
 0.7 (2.8)  0.1 (7.3) 6.7 (9.6) 
Dibenzothiophene  0.1 (2.5)  0.0 (3.5) 2.8 (5.2) 
C1-DBT 
c 
 0.3 (2.5)  0.1 (4.8) 6.1 (5.9) 
C2-DBT 
d 
 0.3 (3.7)  0.1 (5.0) 5.8 (6.4) 
Fluoranthene  0.1 (2.1)  0.1 (3.3) 2.6 (4.0) 
Pyrene  0.1 (2.6)  0.1 (3.3) 2.7 (4.9) 
1-MNAP 
e 
 0.7 (0.7)  0.7 (1.6) 1.0 (2.1) 
2-MNAP 
f 
 1.1 (0.7)  1.0 (2.0) 1.1 (3.4) 
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Table 3. Cont. 
COMPOUND CORD BLOOD 
GM (GSD) ng/mL 
MATERNAL BLOOD 
GM (GSD) ng/mL 
CORD/MATERNAL RATIO 
GM (GSD) 
2,6-DMNAP 
g 
 0.5 (28.7)  0.2 (1.5)  2.7 (1.8) 
1,6,7-TMNAP 
h 
 0.1 (8.4)  0.1 (1.1)  2.3 (1.1) 
1-MPA 
i 
 0.2 (10.2)  0.1 (1.3)  3.4 (1.2) 
    
Total PAHs 
j 
 14.1 (1.7)  7.4 (2.0)  1.9 (2.1) 
a 
C1-phenanthrene/anthracenes; 
b 
C2-phenanthrene/anthracenes; 
c 
C1-dibenzothiophenes;  
d 
C2-di-benzothiophenes; 
e 
1-methylnaphthalene; 
f 
2-methylnaphthalene; 
g 
2,6-dimethylnaphthalene;  
h 
1,6,7-trimethylnaphthalene; 
i 
1-methylphenathrene; 
j 
Total PAHs = sum of all PAH concentrations >0 
(including those not reported in the Table).  
Table 4. Summary statistics for PAH concentrations in matched pairs of maternal and cord 
blood collected within 24-hours of each other (N = 6). 
COMPOUND CORD BLOOD 
GM(GSD) ng/mL 
MATERNAL BLOOD 
GM (GSD) ng/mL 
CORD/MATERNAL RATIO  
GM (GSD) 
Naphthalene 1.5 (1.4) 1.2 (1.3)  1.2 (1.6) 
C1-Naphthalenes 1.0 (1.3) 0.8 (1.3)  1.3 (1.5) 
C2-Naphthalenes 1.3 (1.2) 0.5 (3.2)  2.4 (3.6) 
C3-Naphthalenes 1.1 (1.5) 0.2 (3.8)  6.7 (5.3) 
C4-Naphthalenes 0.9 (4.1) 0.2 (5.3)  3.7 (5.6) 
Biphenyl 0.5 (1.4) 0.4 (1.4)  1.4 (1.9) 
Acenaphthene 0.1 (1.3) 0.1 (1.5)  0.8 (1.8) 
Dibenzofuran 0.4 (1.5) 0.3 (1.5)  1.2 (2.0) 
Fluorene 0.3 (1.7) 0.1 (2.0)  2.5 (2.9) 
C1-Fluorenes 0.7 (1.4) 0.1 (2.8)  5.1 (3.7) 
C2-Fluorenes 0.9 (1.7) 0.1 (3.1)  6.4 (5.1) 
C3-Fluorenes 0.3 (4.1) 0.1 (1.0)  5.5 (4.1) 
Anthracene 0.1 (1.3) 0.1 (1.0)  1.8 (1.3) 
Phenanthrene 0.7 (1.3) 0.4 (1.6)  1.8 (1.8) 
C1-P/A 
a 
0.8 (1.4) 0.1 (3.3)  5.5 (3,9) 
C2-P/A 
b 
0.6 (1.3) 0.1 (2.8)  4.5 (3.7) 
Dibenzothiophene 0.1 (1.0) 0.1 (1.5)  1.4 (1.5) 
C1-DBT
c 
0.3 (1.5) 0.1 (2.0)  3.5 (2.6) 
C2-DBT
d 
0.3 (2.4) 0.1 (2.1)  2.6 (2.8) 
Fluoranthene 0.1 (1.4) 0.1 (1.4)  1.6 (1.8) 
Pyrene 0.1 (1.3) 0.1 (1.4)  1.8 (1.7) 
1-MNAP
e 
0.7 (1.3) 0.5 (1.3)  1.3 (1.4) 
2-MNAP
f 
1.1 (1.3) 0.8 (1.3)  1.4 (1.5) 
2,6-DMNAP
g 
0.6 (1.4) 0.3 (2.2)  2.0 (2.7) 
1,6,7-TMNAP
h 
0.1 (1.6) 0.1 (1.5)  1.5 (2.0) 
1-MPA
i 
0.2 (1.6) 0.1 (1.5)  2.0 (1.9) 
    
Total PAHs
j 
 12.8 (1.3)  5.5 (1.7)  2.3 (2.1) 
a 
C1-phenanthrene/anthracenes; 
b 
C2-phenanthrene/anthracenes; 
c 
C1-dibenzothiophenes;  
d 
C2-di-benzothiophenes; 
e 
1-methylnaphthalene; 
f 
2-methylnaphthalene; 
g 
2,6-dimethylnaphthalene;  
h 
1,6,7-trimethylnaphthalene; 
i 
1-methylphenathrene; 
j 
Total PAHs = sum of all PAH concentrations >0 
(including those not reported in the Table).  
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As shown in Table 4, the general pattern is the same for the 6 matched sample pairs collected in 
close time proximity, with C/M ratios greater than 1.0 for all PAHs, except acenaphthene. The 
geometric mean C/M ratio for total PAHs is 2.3, compared to 1.9 for all 35 matched blood pairs. 
Relatively strong negative correlations (range -0.45 to -0.97) were observed between cord and 
maternal blood concentrations for 13 of 26 PAH compounds and for total PAHs.  
4. Discussion and Conclusions 
Pregnant women in the U.S. are regularly exposed to PAHs in the air they breathe, the water they 
drink, the food and beverages they consume, and the dust and soil they touch [26,34]. Environmental 
chemicals like PAHs can, depending on their intrinsic properties, cross the placenta by a variety of 
mechanisms such as facilitated diffusion, passive diffusion, active transport, and filtration. Once in the 
placenta, xenobiotic chemicals can be acted on by enzymes and metabolized into toxic or non-toxic 
metabolites that can enter the fetal blood stream, or they can accumulate [7].  
Many PAHs have been shown to cross the placental boundary in experimental animal  
studies [35,36], and results indicate that fetal dose is at least an order of magnitude lower than maternal 
dose. Yet rodent bioassays also suggest that levels of fetal DNA-PAH adducts [37], DNA single-strand 
breaks and micronuclei formation [37,38] are higher compared to maternal tissues. Because PAH  
half-life in blood is relatively short, on the order of a few hours, human exposures are typically 
measured using either urinary metabolites [21] or DNA-PAH adducts in blood [13-18]. Although 
comparatively few direct measurements of blood-level PAHs have been reported, there is empirical 
evidence demonstrating that PAHs are present routinely in the human placenta [39] and that PAH 
concentrations in cord blood are often higher than in maternal blood [40-42]. Consistent with earlier 
studies, our results document generally higher PAH concentrations in cord compared to paired 
maternal blood for Hispanic women in Brownsville. 
Although the significance of these findings for fetal health and development is unknown, there are 
reasons for concern. The National Toxicology Program (NTP) and the U.S. Environmental Protection 
Agency (EPA) list many PAHs as “known, probable, or possible” human carcinogens [43,44]. Animal 
bioassays have demonstrated that PAHs are transplacental carcinogens and that the fetus and neonate 
are more susceptible to PAH-caused carcinogenesis than adults [45,46]. Analogous data for humans 
are lacking, but it is clear that the human fetus is more vulnerable to the carcinogenic effects of 
pharmacological drugs like diethylstilbestrol [47]. In addition, PAHs have also been shown to 
adversely affect the immune system [48], reduce fetal growth [13], and cause harmful 
neurodevelopmental effects [18]. 
The 35 women enrolled in this study appear to be from a comparatively high socioeconomic 
stratum because, first, they sought out and could afford prenatal care at a private clinic and, second, as 
shown in Table 1, they were relatively well educated and most worked outside the home. Nevertheless, 
it is likely that they shared at least some of the common problems routinely encountered by the 
predominately Hispanic population of Brownsville, which exhibits many of the socioeconomic 
attributes known to be associated with poor health outcomes; including, poverty, illiteracy, inadequate 
housing, unemployment, use of English as a second language, substandard diet, lack of access to health 
care and, in general, more stressful and less healthful lives [49-51]. Residents often lack access to 
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clean drinking water and adequate sewage treatment facilities, cannot afford air conditioning, 
experience frequent flooding, and are deficient in knowledge about healthy lifestyles [49,50]. 
Contaminated drinking and recreational water is a problem, air pollution is generated by motor 
vehicles, industrial facilities, agricultural operations, and open burning of trash, and the land is fouled 
by scrap yards, tire dumps, and pesticide use [52]. Brownsville residents experience above-average 
prevalence rates for many chronic diseases with an environmental component, including obesity, 
diabetes, tuberculosis, and cardiovascular disease [49-51], and children living along the Texas-Mexico 
border are hospitalized with asthma at a 36% higher rate than non-border children [46]. Overall, the 
available evidence suggests that pregnant women (and their fetuses) living in Brownsville are likely to 
experience elevated cumulative health risks from regular exposure to a complex concoction of 
chemical and nonchemical stressors [49-53]; a situation that could make them more susceptible to the 
adverse effects of PAHs and other environmental chemicals [54,55]. 
Because so few studies have reported direct measurements of PAHs in maternal and cord blood, and 
because those that have used different analytical techniques to monitor disparate populations, it is not 
possible to put measured PAH concentrations into perspective by comparing them to statewide or 
national distributions. However, we do know that the developing fetus is exquisitely sensitive to 
xenobiotic chemicals during certain time windows of vulnerability, and that even minute amounts of 
exogenous substances can produce adverse outcomes in the fetus or developing infant [3,4,7,8,10]. 
There is mounting evidence of reduced birth weight [15,17], decreased postnatal weight gain [16], 
smaller head circumference [14,15], impaired cognitive development [18], and increased susceptibility 
to procarcinogenic DNA damage [15] from prenatal exposure to relatively low levels of PAHs. This 
raises questions about the potentially harmful effects of relatively minimal PAH concentrations on the 
developing fetus, especially given its inherent biological vulnerability, the potential for synergistic 
interactions between multiple chemical and nonchemical stressors, and the likelihood  
that susceptibility is enhanced by socioeconomically-difficult and environmentally-demanding  
living conditions. 
Our results demonstrate that pregnant Hispanic women and their fetuses residing in Brownsville are 
routinely exposed to a diversity of PAHs at comparatively low levels, and that concentrations in 
umbilical cord blood tend to be higher than in maternal blood. Although the cohort is a relatively-small 
convenience sample, and quantifiable PAH levels were often below the nominal limit of detection, 
nevertheless, results document in utero exposure to various PAHs, many of which are known 
neurodevelopmental toxicants and/or human carcinogens. Because women in our study were relatively 
better educated and more affluent than most residents of Brownsville, future studies should investigate 
exposures for the poorest and least educated segment of the Brownsville population, including an 
examination of possible associations between measured concentrations of exposure biomarkers and 
adverse health outcomes. 
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Appendix A 
Table A1. Limits of Detection (LOD) for 19 Compounds that were not Measurable in 
100% of Cord and Maternal Blood Specimens (N = 35 matched sample pairs). 
COMPOUND 
(PAH) 
LOD 
ng/mL
 
C1-Benzothiophenes
 
2.09 
C2-Benzothiophenes
 
2.09 
C3-Benzothiophenes
 
2.09 
C3-Phenanthrenes/Anthracenes 1.74 
C4-Phenathrenes/Antrhacenes 1.74 
C3-Dibenzothiophenes 1.83 
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Table A1. Cont. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A2. Limits of Detection (LOD) and Number of Cord and Maternal Blood Specimens 
(a) less than 0.1 ng/mL, (b) between 0.1 ng/mL and the Limit of Detection, and (c) greater 
than the Limit of Detection for 10 Compounds not Measurable in ≥80% to ≤99% of 
Samples (N = 35 matched sample pairs). 
COMPOUND 
(PAH) 
LOD 
ng/mL
 
# of CORD SPECIMENS # of MATERNAL SPECIMENS 
<0.1
a 
0.1
a
–LOD >LOD <0.1
a 
0.1
a
–LOD >LOD 
Benzothiophene
 
1.04 34 1 0 35 0 0 
Acenaphthylene 1.16 34 1 0 33 2 0 
Carbazole 1.96 28 7 0 29 6 0 
C1-F/P
b 
2.02 30 5 0 33 2 0 
C2-F/P
c 
2.02 35 0 0 34 1 0 
Benzo(a)anthracene
 
0.77 35 0 0 30 5 0 
Chrysene 1.04 35 0 0 32 3 0 
Benzo(b)fluoranthene
 
1.74 35 0 0 34 1 0 
Benzo(e)pyrene
 
1.83 35 0 0 34 1 0 
Perylene 1.97 35 0 0 31 4 0 
a 
ng/mL; 
b 
C1-fluoranthenes/pyrenes; 
c 
C2-fluoranthenes/pyrenes. 
COMPOUND 
(PAH) 
LOD 
ng/mL
 
Naphthobenzothiophene
 
1.23 
C1-Naphthobenzothiophenes
 
2.02 
C2-Naphthobenzothiophenes
 
2.02 
C3-Naphthobenzothiophenes
 
2.02 
C1-Chrysenes
 
2.09 
C2-Chrysenes
 
2.09 
C3-Chrysenes
 
2.09 
C4-Chrysenes 2.09 
Benzo(k)fluoranthene
 
1.36 
Benzo(a)pyrene
 
1.32 
Indeno(1,2,3-c,d)pyrene
 
1.68 
Dibenzo(a,h)anthracene
 
0.92 
Benzo(g,h,i)perylene
 
0.87 
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Table A3. Limits of Detection (LOD) and Number of Cord and Maternal Blood Specimens 
(a) less than 0.1 ng/mL, (b) between 0.1 ng/mL and the Limit of Detection, and (c) greater 
than the Limit of Detection for 26 Compounds included in the Statistical Analysis (N = 35 
matched sample pairs). 
COMPOUND 
(PAH) 
LOD 
ng/mL
 
# of CORD SPECIMENS # of MATERNAL SPECIMENS 
<0.1 
a 
0.1 
a
–LOD >LOD <0.1 
a 
0.1 
a
–LOD >LOD 
Naphthalene 1.04 0 10 25 0 7 28 
C1-Naphthalenes 1.99 0 24 11 0 26 9 
C2-Naphthalenes 2.09 0 26 9 8 23 4 
C3-Naphthalenes 2.09 3 24 8 13 18 4 
C4-Naphthalenes 2.09 11 19 5 18 15 2 
Biphenyl 0.87 0 34 1 0 35 0 
Acenaphthene 0.77 25 10 0 18 17 0 
Dibenzofuran 1.23 0 35 0 20 15 0 
Fluorene 1.04 0 35 0 8 27 0 
C1-Fluorenes 2.08 0 33 2 10 25 0 
C2-Fluorenes 2.08 1 26 8 13 21 1 
C3-Fluorenes 2.08 17 17 1 31 4 0 
Anthracene 1.12 9 26 0 22 13 0 
Phenanthrene 0.87 0 27 8 1 34 0 
C1-P/A
b 
1.74 0 28 7 12 23 0 
C2-P/A
c 
1.74 1 27 7 15 20 0 
Dibenzothiophene 0.92 4 31 0 17 18 0 
C1-DBT
d 
1.83 1 34 0 16 19 0 
C2-DBT
e 
1.83 3 32 0 16 19 0 
Fluoranthene 1.26 1 34 0 11 24 0 
Pyrene 1.07 3 32 0 13 22 0 
1-MNAP
f 
0.77 0 28 7 0 25 10 
2-MNAP
g 
1.23 0 25 10 0 25 10 
2,6-DMNAP
h 
1.23 0 35 0 8 27 0 
1,6,7-TMNAP
i 
0.58 3 32 0 7 28 0 
1-MPA
j 
1.23 0 35 0 6 29 0 
a 
ng/mL; 
b 
C1-phenanthrene/anthracenes; 
c 
C2-phenanthrene/anthracenes; 
d 
C1-dibenzothiophenes; 
  
e 
C2-dibenzothiophenes; 
f 
1-methylnaphthalene; 
g 
2-methylnaphthalene; 
h 
2,6-dimethylnaphthalene; 
  
i 
1,6,7-trimethylnaphthalene; 
j 
1-methylphenanthrene. 
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